In the world of diabetes management, the choice of medication can significantly impact a patient’s quality of life. With the rise of diabetes prevalence globally, various medications have emerged to help individuals manage their blood sugar levels effectively. Among these, Farxiga and Tradjenta are two commonly prescribed medications that serve distinct purposes in diabetes treatment. Understanding the differences and similarities between these two drugs can empower patients and healthcare providers to make informed decisions tailored to individual needs. Farxiga, known generically as dapagliflozin, is part of a class of medications called SGLT2 inhibitors. It works by preventing the reabsorption of glucose in the kidneys, allowing excess sugar to be excreted…